Natamycin - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for natamycin and what is the scope of patent protection?

Natamycin is the generic ingredient in one branded drug marketed by Harrow Eye and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for natamycin. Two suppliers are listed for this compound.

Summary for natamycin

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	35
Clinical Trials:	7
What excipients (inactive ingredients) are in natamycin?	natamycin excipients list
DailyMed Link:	natamycin at DailyMed

Recent Clinical Trials for natamycin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Stanford University	Phase 3
Aravind Eye Care System	Phase 3
Thomas M. Lietman	Phase 3

See all natamycin clinical trials

Pharmacology for natamycin

Drug Class	Polyene Antimicrobial

Medical Subject Heading (MeSH) Categories for natamycin

Anti-Bacterial Agents
Anti-Infective Agents, Local
Antifungal Agents

US Patents and Regulatory Information for natamycin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Harrow Eye	NATACYN	natamycin	SUSPENSION;OPHTHALMIC	050514-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.